08.10. - 09.10.2026
About the Conference
This international conference is hosted by FOR5560, a DFG-funded research group bringing together immunologists from Munich, Erlangen, Freiburg, and Berlin. Our shared mission is to understand how cellular metabolism and signalling pathways shape B cell biology and how these processes contribute to autoimmune and tumour diseases.
Across seven interconnected projects, our scientists investigate different facets of B cell metabolism and signal transduction, with the aim of pooling expertise, building new collaborations, and uncovering novel therapeutic approaches for B cell–driven diseases.
This two-day meeting at TranslaTUM in Munich brings together leading international researchers, our consortium members, early-career scientists, and industry partners for an intensive exchange of ideas at the frontier of B cell biology.
What to Expect
World-class invited speakers: We are delighted to welcome six internationally renowned researchers:
- Victor Tybulewicz, The Francis Crick Institute, London (UK)
- Dinis Calado, The Francis Crick Institute, London (UK)
- Annemiek van Spriel, Radboud University, Nijmegen (NL)
- Alex Clarke, Kennedy Institute of Rheumatology, Oxford (UK)
- Marion Espéli, Inserm, Paris (FR)
- Jérôme Paggetti, Luxembourg Institute of Health (LU)
Short talks from the FOR5560 projects, presenting the latest results from our consortium.
Selected short talks chosen from submitted abstracts, giving early-career researchers a platform to share their work alongside established leaders in the field.
A poster session offering space for in-depth discussion and one-to-one exchange.
A networking evening on Day 1 with food, drinks, and music: a relaxed setting to continue conversations sparked during the day.
Closing discussion and awards on Day 2 to round off the meeting, followed by individual and TAC meetings for FOR5560 members.